Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS.

Cancer - 15 Nov 2012

Kadia Tapan M, Kantarjian Hagop, Kornblau Steven, Borthakur Gautam, Faderl Stefan, Freireich Emil J, Luthra Raja, Garcia-Manero Guillermo, Pierce Sherry, Cortes Jorge, Ravandi Farhad

Abstract excerpt

BACKGROUND: Activating mutations in RAS are frequently present in patients with acute myeloid leukemia (AML), but their overall prognostic impact is not clear. METHODS: A retrospective analysis was performed to establish the clinical characteristics of patients with RAS-mutated (RAS(mut) ) AML, t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Cytarabine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Genes, ras

Share to Leukemia, Myeloid, Acute

Share to Proteomics

Share to ras Proteins

Share to Remission Induction

Source

Open in PubMed Open full text

Identifiers

PMID: 22569880
DOI: 10.1002/cncr.27596
PMCID: PMC3416961

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22569880-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS.PMID 22569880Read ↗

Clinico-genomic characterization of RAS-mutant acute myeloid leukemia.Semantic proximity Read ↗

RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives.Semantic proximity Read ↗

[Clinical characteristics and prognostic implications of RAS mutations in newly diagnosed acute myeloid leukemia with normal karyotype based on next-generation sequencing analysis].Semantic proximity Read ↗

BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild‐type RASSemantic proximity Read ↗

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.Semantic proximity Read ↗

Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes.Semantic proximity Read ↗

Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.Semantic proximity Read ↗

Deregulation of signaling pathways in acute myeloid leukemia.Semantic proximity Read ↗

Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.Semantic proximity Read ↗

Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia.Semantic proximity Read ↗

Advances and Challenges in RAS Signaling Targeted Therapy in Leukemia.Semantic proximity Read ↗

Targeting Ras in myeloid leukemias.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.